NRSN logo

NeuroSense Therapeutics (NRSN) Earnings Per Share

Annual EPS

-$0.83
+$0.24+22.43%

December 1, 2023


Summary


Performance

NRSN EPS Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNRSNprofitabilitymetrics:

Quarterly EPS

-$0.11
-$0.09-450.00%

September 1, 2024


Summary


Performance

NRSN Quarterly EPS Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNRSNprofitabilitymetrics:

TTM EPS

-$0.76
-$0.11-16.92%

September 1, 2024


Summary


Performance

NRSN TTM EPS Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNRSNprofitabilitymetrics:

EPS Formula

EPS =  
Net Income - Preferred Dividends
Shares Outstanding

NRSN EPS Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+22.4%+68.6%+18.3%
3 y3 years-221.2%+64.5%-18.4%
5 y5 years-643.1%+43.3%-291.6%

NRSN EPS Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-27.7%+22.4%<-9999.0%+68.6%-105.1%+29.6%
5 y5-year-643.1%+22.4%<-9999.0%+68.6%-291.6%+29.6%
alltimeall time-643.1%+22.4%<-9999.0%+68.6%-291.6%+29.6%

NeuroSense Therapeutics EPS History

DateAnnualQuarterlyTTM
Sep 2024
-
-$0.11(+450.0%)
-$0.76(+16.9%)
Jun 2024
-
-$0.02(-94.3%)
-$0.65(-30.1%)
Mar 2024
-
-$0.35(+25.0%)
-$0.93(+12.0%)
Dec 2023
-$0.83(-22.4%)
-$0.28(<-9900.0%)
-$0.83(+1.2%)
Sep 2023
-
$0.00(-100.0%)
-$0.82(-23.4%)
Jun 2023
-
-$0.30(+20.0%)
-$1.07(-0.9%)
Mar 2023
-
-$0.25(-7.4%)
-$1.08(+0.9%)
Dec 2022
-$1.07
-$0.27(+8.0%)
-$1.07(+32.2%)
Sep 2022
-
-$0.25(-19.4%)
-$0.81(+26.1%)
DateAnnualQuarterlyTTM
Jun 2022
-
-$0.31(+29.2%)
-$0.64(+54.1%)
Mar 2022
-
-$0.24(+2508.7%)
-$0.42(+12.4%)
Dec 2021
-$0.65(+151.5%)
-
-
Dec 2021
-
-$0.01(-88.8%)
-$0.37(+2.5%)
Sep 2021
-
-$0.08(-2.7%)
-$0.36(+29.6%)
Jun 2021
-
-$0.08(-56.3%)
-$0.28(+43.7%)
Mar 2021
-
-$0.19
-$0.19
Dec 2020
-$0.26(+131.3%)
-
-
Dec 2019
-$0.11
-
-

FAQ

  • What is NeuroSense Therapeutics annual earnings per share?
  • What is the all time high annual EPS for NeuroSense Therapeutics?
  • What is NeuroSense Therapeutics annual EPS year-on-year change?
  • What is NeuroSense Therapeutics quarterly earnings per share?
  • What is the all time high quarterly EPS for NeuroSense Therapeutics?
  • What is NeuroSense Therapeutics quarterly EPS year-on-year change?
  • What is NeuroSense Therapeutics TTM earnings per share?
  • What is the all time high TTM EPS for NeuroSense Therapeutics?
  • What is NeuroSense Therapeutics TTM EPS year-on-year change?

What is NeuroSense Therapeutics annual earnings per share?

The current annual EPS of NRSN is -$0.83

What is the all time high annual EPS for NeuroSense Therapeutics?

NeuroSense Therapeutics all-time high annual earnings per share is -$0.11

What is NeuroSense Therapeutics annual EPS year-on-year change?

Over the past year, NRSN annual earnings per share has changed by +$0.24 (+22.43%)

What is NeuroSense Therapeutics quarterly earnings per share?

The current quarterly EPS of NRSN is -$0.11

What is the all time high quarterly EPS for NeuroSense Therapeutics?

NeuroSense Therapeutics all-time high quarterly earnings per share is $0.00

What is NeuroSense Therapeutics quarterly EPS year-on-year change?

Over the past year, NRSN quarterly earnings per share has changed by +$0.24 (+68.57%)

What is NeuroSense Therapeutics TTM earnings per share?

The current TTM EPS of NRSN is -$0.76

What is the all time high TTM EPS for NeuroSense Therapeutics?

NeuroSense Therapeutics all-time high TTM earnings per share is -$0.19

What is NeuroSense Therapeutics TTM EPS year-on-year change?

Over the past year, NRSN TTM earnings per share has changed by +$0.17 (+18.28%)